Efficacy and Safety of Obinutuzumab in Immune-Mediated Thrombotic Thrombocytopenic Purpura

Am J Hematol. 2024 Dec 12. doi: 10.1002/ajh.27550. Online ahead of print.
No abstract available

Keywords: ADAMTS13; obinutuzumab; prognosis; relapse; thrombotic thrombocytopenic purpura.

Publication types

  • Letter